Gaudium IVF IPO

Listed Mainboard
Min Investment
₹14,931
189 Shares
Min Investment
₹14,931 · 189 Shares
Price Band ₹75–79
Lot Size 189 shares
Issue Size ₹165 Cr
Listed At ₹83.00 +5.1%
Subscribed 7.27×
Listed On BSE & NSE

Gaudium IVF IPO Listing Day Performance

Gaudium IVF listed on BSE & NSE on 27 February 2026 at ₹83.00, a 5.06% premium over the issue price of ₹79. A retail investor allotted one lot of 189 shares gained ₹756 at the listing price.

Issue price
₹79
final price
Listing price
₹83.00
pre-open auction
Listing gain
+5.06%
+₹4 per share
Profit per application
+₹756
189 shares

GMP vs actual listing

Last GMP before listing₹-4 (-5.1%)
GMP-implied listing₹75
Actual listing₹83.00
Difference+₹8 (+10.7%)

Demand going into listing

Subscribed overall7.27×
QIB1.62×
NII14.05×
Retail7.6×
Listing price = opening price from the exchange's pre-open call auction on listing day. Watch live price

Market Sentiment

Grey Market Premium What is GMP?
₹-4
-5.1% ▼ ₹4 since last update
Est. listing ₹75
Issue price ₹79
GMP range ₹-4 – ₹10
13 Feb · ₹0 26 Feb · ₹-4
Updated 26 Feb, 12:00 am IST Unofficial grey-market data
GMP estimate ₹75
Actual listing ₹83
Listed above the GMP estimate by ₹8 (+10.7%)
Subscription Status
QIB
1.62x
NII
14.05x
bNII (>10L)
12.71x
sNII (2-10L)
16.73x
Retail
7.60x
Total
7.27x
Updated: Mar 02, 2026 10:51 pm IST
Analysis Score 41 / 100
Mixed Signals
Data: 80%
GMP Score · 44% weight 20
Subscription Score · 38% weight 42
Financial Health · 19% weight 86
Weighted average of the parts above; updates as GMP and subscription change. not investment advice.

IPO Details

Price Band₹75–79 per equity share
Face Value₹5 Per Equity Share
Lot Size 189 shares (Min ₹14,931)
Total Issue Size ₹165.00 crore
Fresh Issue₹90.00 crore
Offer For Sale₹75.00 crore
Fresh vs OFS
Fresh 55% · to the company OFS 45% · to selling shareholders
Issue TypeBook build Issue
Lead Manager Sarthi Capital Advisors Pvt. Ltd.
Registrar Bigshare Services Pvt. Ltd.
Listing atBSE & NSE
BSE Code544709
NSE SymbolGAUDIUMIVF
ISININE0P8B01020
Listing Price₹83.00
Listing Gain+5.06%

Market Lot Size

Category Lots Shares Amount (₹)
Retail Minimum 1 189 ₹14,931
Retail Maximum 13 2,457 ₹1,94,103
S-HNI Minimum 14 2,646 ₹2,09,034
S-HNI Maximum 66 12,474 ₹9,85,446
B-HNI Minimum 67 12,663 ₹10,00,377

IPO Reservation

QIB 20% NII 15% Retail 35% Anchor 30%
Category Shares Offered Shares %
QIB41,77,24020.00%
NII (HNI)31,32,93015.00%
bNII > ₹10L20,88,62010.00%
sNII < ₹10L10,44,3105.00%
Retail73,10,17035.00%
Anchor62,65,86030.00%
Total2,08,86,200

Financial Analysis

Financial Data

ROE
41.31%
ROCE
39.70%
Debt/Equity
0.41
NAV/Share
₹7.54
Revenue Growth
47.37%
Profit Margin
26.96%

Financial Performance

2025 vs 2024 Revenue +47.4% Profit (PAT) +85.4% Total Assets +73.5%
Metric 2023 2024 2025
Revenue 44.26 48.15 70.96
Expense 25.95 31.52 45.54
Profit (PAT) 13.53 10.32 19.13
Total Assets 36.63 51.01 88.51
Values in Crores (₹)

Promoters & Holding Pattern

Promoters: Dr. Manika Khanna, Dr. Peeyush Khanna and Vishad Khanna

Shareholding No. of Shares Holding %
Promoter Holding Pre Issue 6,13,94,384 99.99%
Promoter Holding Post Issue 7,27,86,884 71.30%

Strengths & Risks

Strengths
  • Strongly subscribed — 7.3x overall (final).
  • Revenue grew 47% in the latest reported year.
  • Solid profit margin — 27.0%.
  • Strong return on equity — 41%.
Risks & Concerns

Our data checks haven't flagged a specific concern for Gaudium IVF — but that isn't a clean bill of health. Read the risk-factors section of the RHP, which lists company-specific risks our data can't capture.

From this issue's live data. Not investment advice — read the RHP.

Company Information

Gaudium IVF at a glance

From the company's description: “Gaudium IVF, founded in March 2015, is one of the leading companies offering In Vitro Fertilization (IVF) treatments for women across India.”

Gaudium IVF is raising ₹165 crore through an IPO on the BSE and NSE mainboard. Of that, ₹90 crore is a fresh issue — new shares, with the money going to the company — and ₹75 crore is an offer for sale by existing shareholders, who keep those proceeds; 55% of the issue therefore reaches the business. Main stated uses of the fresh money: Funding capital expenditure towards establishment of New IVF Centers of the Company (₹50 crore) and Repayment/pre-payment, in full or in part, of certain outstanding loans availed by our Company; and (₹20 crore).

Revenue went from ₹44.26 crore in 2023 to ₹70.96 crore in 2025, up 60% over 2 years. Profit after tax went from ₹13.53 crore to ₹19.13 crore, a net margin of 27% in the latest year.

The promoters, Dr. Manika Khanna and Dr. Peeyush Khanna and Vishad Khanna, hold 100% before the issue and 71% after it — a dilution of 28.7 percentage points. Debt stands at 0.41 times equity.

Written from the issue's offer-document figures shown on this page. Not investment advice.

Company Contact Information

Gaudium IVF & Women’s Health Ltd., B1/51,, Janak Puri,, B-1,, New Delhi, New Delhi, 110058

Objects of the Issue

Purpose Amount (Cr)
Funding capital expenditure towards establishment of New IVF Centers of the Company 50.00
Repayment/pre-payment, in full or in part, of certain outstanding loans availed by our Company; and 20.00
General Corporate Purpose -

Resources & Documents

Anchor Investors

Anchor Bidding Date
February 19, 2026
Shares Offered to Anchors
62,65,860
Lock-in End (30 Days, 50%)
March 27, 2026
Lock-in End (90 Days, 50%)
May 26, 2026

Gaudium IVF IPO - Quick Take

Gaudium IVF has set a price band of Rs 75–Rs 79 per share for an issue size of Rs 165 crore. The stock listed with a 5.06% gain versus its issue price on February 27, 2026.

The issue is promoted by Dr. Manika Khanna, Dr. Peeyush Khanna and Vishad Khanna with Sarthi Capital Advisors Pvt. Ltd. acting as lead manager. Net proceeds will primarily be used towards funding capital expenditure towards establishment of New IVF Centers of the Company (Rs 50 crore) and repayment/pre-payment, in full or in part, of certain outstanding loans availed by our Company; and (Rs 20 crore).

On fundamentals, the company is posting revenue growth of 47.4%, a profit margin of 27.0%, return on equity of 41.3% in its most recent reported period.

On our data-signal score, the combined signals for this issue currently read mixed — some indicators read positively and others do not. This is a summary of public data, not a recommendation to apply or skip. Past performance does not predict future returns — review the price chart and peer comparison below before trading.

Gaudium IVF IPO: Lead Manager & Registrar Track Record

How the firm running this issue and its registrar have fared on the other IPOs we track. Each firm's figures leave out Gaudium IVF itself, so they describe what came before it.

Mainboard IPOs, last 12 months
  • Gaudium IVF listed at +5.1% on day one; the median of 113 listings was +7% (better than 44% of them).
  • Subscribed 7.27x against a median of 20.56x across 111 issues (higher than 39%).
  • Average listing-day move across all 114 Mainboard listings we track: +13.6%.
Lead manager and registrar record on other IPOs we track
Firm Other IPOs Listed at / above issue Avg move Median
Sarthi Capital Advisors Pvt. Ltd. Lead manager 1 1 MB · 0 SME 100% 1 of 1 +31.1% +31.1%
Bigshare Services Pvt. Ltd. Registrar 61 18 MB · 43 SME 67% 41 of 61 Check allotment →
Recent listings managed by Sarthi Capital Advisors Pvt. Ltd. (1)
IPOListedListing-day move
Jindal Supreme 23 Sep 2026 +31.1%
What a lead manager does

A SEBI-registered merchant banker that runs the issue: due diligence, drafting the offer document, setting the price band with the company, and marketing the IPO to investors.

What a registrar does

Finalises the basis of allotment, credits shares to demat accounts, releases blocked funds for unsuccessful bids and handles investor queries about the issue.

Listing-day move = exchange opening price vs issue price (band ceiling where the final price isn't recorded). Counts cover IPOs we track only. Past listings don't predict this one; this is not investment advice.

Frequently Asked Questions

Gaudium IVF listed at Rs 83.00 on 27 February 2026, against an issue price of Rs 79 — a 5.06% premium.

+5.06% at the listing price — Rs 4 per share, or Rs 756 on the minimum retail application of 189 shares.

The price band of Gaudium IVF IPO is Rs 75 to Rs 79 per share. Face value is Rs 5 per share.

The total issue size of Gaudium IVF IPO is Rs 165 crore, comprising fresh issue of Rs 90 crore and offer for sale (OFS) of Rs 75 crore.

The lot size of Gaudium IVF IPO is 189 shares. The minimum application is 1 lot (189 shares), requiring an investment of Rs 14,931. Maximum retail application is 13 lots (2,457 shares, approx Rs 1,94,103).

Gaudium IVF IPO opens for subscription on February 20, 2026 and closes on February 24, 2026. Anchor investor bidding is scheduled for February 19, 2026.

The expected allotment date for Gaudium IVF IPO is February 25, 2026. Refunds for unsuccessful applicants are expected on February 26, 2026.

Gaudium IVF IPO is scheduled to list on February 27, 2026 on both BSE and NSE. BSE script code: 544709, NSE symbol: GAUDIUMIVF, ISIN: INE0P8B01020.

The last GMP (Grey Market Premium) recorded for Gaudium IVF IPO before listing was Rs -4 (-5.1% over issue price). The shares actually listed at Rs 83 (+5.06% versus the issue price). GMP only estimates the listing price and stops mattering once the shares trade.

Gaudium IVF IPO was subscribed 7.27 times overall by the close of bidding — retail at 7.60x, QIB at 1.62x, NII at 14.05x.

Based on the final retail subscription of 7.60x for Gaudium IVF IPO, the estimated retail allotment probability is approximately 15.0%. This is a moderate probability of allotment.

The registrar for Gaudium IVF IPO is Bigshare Services Pvt. Ltd. After the allotment date, you can check your allotment status on the registrar's official website by entering your PAN, application number, or demat account details. Allotment status is also available on the BSE and NSE websites.

The book running lead manager(s) for Gaudium IVF IPO are Sarthi Capital Advisors Pvt. Ltd.

The promoter(s) of Gaudium IVF are Dr. Manika Khanna, Dr. Peeyush Khanna and Vishad Khanna.

Gaudium IVF IPO GMP — What It Means

Its last GMP before listing was -5.1%. Of the 15 Mainboard IPOs we have tracked with a final GMP below zero, 2 listed above, 0 flat and 13 below the issue price; Gaudium IVF listed 5.1% above its issue price.

See the full Gaudium IVF GMP history and trend, or learn how grey market premium works and how reliable it is.

Related IPO

Same sector or same stage as Gaudium IVF
Side by side: GMP, subscription, valuation, financials and listing performance.
0 Comments

No comments yet. Be the first to share your opinion!

GMPUpdate